These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 646850)

  • 1. Fibrinogenemia, determined immunonephelometrically, as a possible parameter in the evaluation of peripheral arteriosclerotic arteriopathy.
    Pola P; Savi L
    Atherosclerosis; 1978 Feb; 29(2):205-16. PubMed ID: 646850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of blood viscosity and fibrinogen as a guide to the therapy of atherosclerotic peripheral arteriopathy].
    Savi I; Pola P
    Minerva Med; 1978 Dec; 69(63):4401-10. PubMed ID: 745806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma fibrinogen as a cardiovascular risk factor].
    Naito M; Hayashi T; Iguchi A
    Nihon Ronen Igakkai Zasshi; 1994 Mar; 31(3):213-8. PubMed ID: 8207872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease.
    Poredos P; Zizek B
    Angiology; 1996 Mar; 47(3):253-9. PubMed ID: 8638868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between hemorheologic parameters and carotid atherosclerosis in stroke.
    Mercuri M; Orecchini G; Susta A; Tazza D; Ciuffetti G
    Angiology; 1989 Apr; 40(4 Pt 1):283-6. PubMed ID: 2650579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary study on erythrocyte filterability and other hemorrheological parameters in arteriosclerotic vascular disease].
    Pernigotti L; Neirotti M
    Ric Clin Lab; 1983; 13 Suppl 3():423-6. PubMed ID: 6673024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorheological aspects in relation to age and to the presence of arteriosclerotic disease].
    Neirotti M; Molaschi M; Pernigotti L; Milla A; Fabris F
    Ric Clin Lab; 1989; 19 Suppl 1():69-74. PubMed ID: 2629090
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study.
    Lowe GD; Fowkes FG; Dawes J; Donnan PT; Lennie SE; Housley E
    Circulation; 1993 Jun; 87(6):1915-20. PubMed ID: 8504504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma thrombin clotting time and plasma fibrinogen in diabetes mellitus and atherosclerosis.
    Banerjee RN; Kumar V; Sahni AL
    Indian J Med Res; 1972 Oct; 60(10):1432-42. PubMed ID: 4661652
    [No Abstract]   [Full Text] [Related]  

  • 10. [Novel risk factors for atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and cholesterol as predictors of peripheral arteriopathy].
    Iacoviello L; Donati MB; de Gaetano G
    Ital Heart J Suppl; 2001 Sep; 2(9):1031-3. PubMed ID: 11675827
    [No Abstract]   [Full Text] [Related]  

  • 11. Can rheologic variables be of prognostic relevance in arteriosclerotic diseases?
    Resch KL; Ernst E; Matrai A; Buhl M; Schlosser P; Paulsen HF
    Angiology; 1991 Dec; 42(12):963-70. PubMed ID: 1763830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increase in erythrocyte and plasma viscosity in patients with atherosclerotic vasculopathy of different sites].
    Craveri A; Tornaghi G; Paganardi L; Di Bella M; Gallo E; Stanzani M
    Minerva Med; 1987 Jun; 78(12):815-22. PubMed ID: 3601129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of behaviour of fibrinogen and of some glycoproteins in arteriosclerotic clinical situations (author's transl)].
    Sarno A; La Bruzzo S; Catania A; Francavilla G; Romano A; Caimi G
    G Ital Cardiol; 1980; 10(1):65-71. PubMed ID: 7461310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients.
    Niort G; Bulgarelli A; Cassader M; Pagano G
    Atherosclerosis; 1988 Jun; 71(2-3):113-9. PubMed ID: 3401284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen genotype and risk of peripheral atherosclerosis.
    Fowkes FG; Connor JM; Smith FB; Wood J; Donnan PT; Lowe GD
    Lancet; 1992 Mar; 339(8795):693-6. PubMed ID: 1347581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrinogen as a cardiovascular risk factor].
    Giannasi G; Ferrari S; Galetta F
    Minerva Cardioangiol; 1995 May; 43(5):169-75. PubMed ID: 7478039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the blood coagulation system in arteriosclerotic patients].
    Zola-Sleczek E
    Folia Med Cracov; 1970; 12(3):297-336. PubMed ID: 5474823
    [No Abstract]   [Full Text] [Related]  

  • 18. [The behavior of the fibrinogen polymerization curve in hypercholesterolemic subjects].
    Alessandri C; Bucci A; Basili S; Pacillo L; Ricci G
    Clin Ter; 1993 Feb; 142(2):115-21. PubMed ID: 8472524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: the Copenhagen City Heart Study.
    Kofoed SC; Wittrup HH; Sillesen H; Nordestgaard BG
    Eur Heart J; 2003 Mar; 24(6):567-76. PubMed ID: 12643890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased platelet and coagulatory activity in peripheral atherosclerosis flow mediated platelet function is a sensitive and specific disease indicator.
    Reininger CB; Graf J; Reininger AJ; Spannagl M; Steckmeier B; Schweiberer L
    Int Angiol; 1996 Dec; 15(4):335-43. PubMed ID: 9127775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.